<DOC>
	<DOCNO>NCT02028169</DOCNO>
	<brief_summary>This post marketing observational study ( PMOS ) design provide initial data work impairment Psoriatic Arthritis ( PsA ) patient Turkey , well change work impairment , life quality clinical response treatment anti-TNF agent .</brief_summary>
	<brief_title>To Observe Impacts Anti-Tumor Necrosis Factor ( TNF ) Effectiveness Improvement Work Place Household Productivity Patients With Psoriatic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<criteria>Actively work , either fulltime parttime Previous confirm diagnosis PsA rheumatologist Patients physician initiate PsA treatment AntiTNF accordance Turkish Ministry Health regulation reimbursement criterion Able provide authorization use disclose health relate information Patients history allergic reaction significant sensitivity antiTNF agent Patients possible followup problem plan study period patient may compliant treatment evaluate investigator/treating physician Patients participate clinical trial experimental drug 30 day prior first visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Work Productivity</keyword>
	<keyword>Anti-TNFs</keyword>
	<keyword>Psoriatic Arthritis</keyword>
</DOC>